{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.ai-analytics.org/api/v1/fda/warning-letters/check?name=ProRx%2C%20LLC","name":"ProRx, LLC","_source":{"data_provider":"AI Analytics","data_provider_url":"https://api.ai-analytics.org","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-09-26T20:23:06.742Z"},"count":1,"matches":[{"id":"731d2253cc33c289","posted_date":"2025-03-04","letter_issue_date":"2025-03-04","company_name":"ProRx, LLC","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"Compounding Pharmacy/Adulterated Drug Products","canonical_url":"https://api.ai-analytics.org/fda-warning/731d2253cc33c289"}]}